SCHEMBL4667627

SCHEMBL4667627

CC(=O)OCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3807247 0.85
SCHEMBL7288316 0.83 ALDH1A1 (0.54)
SCHEMBL8812338 0.81 ALDH1A1 (0.52)
SCHEMBL8811532 0.81 ALDH1A1 (0.52)
SCHEMBL17871475 0.81 ALDH1A1 (0.52)
SCHEMBL8813024 0.81 ALDH1A1 (0.52)
SCHEMBL8814286 0.81 ALDH1A1 (0.52)
SCHEMBL12445284 0.81 ALDH1A1 (0.50)
SCHEMBL967271 0.79
SCHEMBL1235849 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5329016-A Antianxiety, hypnotic agents, antiepileptic agents or nootropics YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1994-07-12 US claimed
US-5175162-A Anxiolytic, antiepilepic agents YOSHITIOMI PHARMACEUTICAL INDUSTRIES LTD. (JP) 1992-12-29 US claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
EP-3369724-B1 PROCESS FOR THE PREPARATION OF IOPAMIDOL BRACCO IMAGING SPA (IT) 2021-01-06 EP disclosed
US-10377700-B2 Process for the recovery of a boronic acid BRACCO IMAGING S.P.A. (IT) 2019-08-13 US disclosed
US-20190077745-A1 PROCESS FOR THE PREPARATION OF IOPAMIDOL BRACCO IMAGING S.P.A. (IT) 2019-03-14 US disclosed
US-20190071392-A1 PROCESS FOR THE PREPARATION OF IOPAMIDOL BRACCO IMAGING S.P.A. (IT) 2019-03-07 US disclosed
EP-3369724-A1 PROCESS FOR THE PREPARATION OF IOPAMIDOL Bracco Imaging SPA (IT) 2018-09-05 EP disclosed
EP-3352749-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS Graybug Vision, Inc. (US) 2018-08-01 EP disclosed
US-9950991-B2 Process for the preparation of iopamidol BRACCO IMAGING S.P.A. (IT) 2018-04-24 US disclosed
EP-3066071-B1 PROCESS FOR THE PREPARATION OF IOPAMIDOL BRACCO IMAGING SPA (IT) 2018-04-18 EP disclosed
EP-0308917-A2 Imidazopyridine compound, a process for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-29 EP disclosed
US-4742057-A Antiallergic thiazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-03 US disclosed
US-4727060-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1988-02-23 US disclosed
US-4719288-A HYPOTENSIVE CIBA-GEIGY CORPORATION (US) 1988-01-12 US disclosed
EP-0224919-A2 New thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-10 EP disclosed
US-4613676-A PEPTIDES CIBA-GEIGY CORPORATION (US) 1986-09-23 US disclosed
EP-0118348-A1 Brominated compounds and opacifying products containing them GUERBET S.A. (FR) 1984-09-12 EP disclosed
US-4365065-A 1-(Pyridinyl)-2-(dimethylamino)ethenyl lower-alkyl ketones STERLING DRUG INC. (US) 1982-12-21 US disclosed
US-4313951-A 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor STERLING DRUG INC. (US) 1982-02-02 US disclosed